Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1984-09-26
1987-08-11
Hazel, Blondel
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
424 85, 435811, C07K 1526, A61K 4502
Patent
active
046862846
ABSTRACT:
Monomeric human .gamma.-interferon is efficiently produced by subjecting crude human .gamma.-interferon to gel filtration in the presence of a reducing sulfur compound and a protein-denaturing agent.
REFERENCES:
patent: 3981991 (1976-09-01), Stewart et al.
patent: 4100150 (1978-07-01), Cartwright
patent: 4278661 (1981-07-01), Knight, Jr.
patent: 4432895 (1984-02-01), Tarnowski
patent: 4476049 (1984-10-01), Kung
Giovanni Di Sabato; Purification and Initial Characterization of Rat Interleukin 2; Proceedings of the National Academy of Sciences; Jan. 1982, vol. 79, No. 1; pp. 3020-3023.
Honda Susumu
Nara Kiyoshi
Buckley Linda M.
Conlin David G.
Hazel Blondel
Takeda Chemical Industries Ltd.
LandOfFree
Production of monomeric human .gamma.-interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of monomeric human .gamma.-interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of monomeric human .gamma.-interferon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-403471